original ) (raw )Risk Assessment of Gastric Cancer and Precancerous Condition Using Serum Pepsinogen and H. Pylori Antibody Test
Erkhembulgan Purevdorj
Central Asian Journal of Medical Sciences
View PDFchevron_right
Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study
Naomi Uemura
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016
View PDFchevron_right
Circulating Anti-Helicobacter pylori Immunoglobulin A Antibodies and Low Serum Pepsinogen I Level Are Associated with Increased Risk of Gastric Cancer
Olli J Heinonen
American Journal of Epidemiology, 1996
View PDFchevron_right
Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study
Ilva Daugule
Diagnostics
View PDFchevron_right
Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels
Azin Nahvijou
Iranian biomedical journal, 2015
View PDFchevron_right
Pepsinogen Test for the Evaluation of Precancerous Changes in Gastric Mucosa: a Population-Based Study
Ilona Kojalo
Journal of Gastrointestinal and Liver Diseases
View PDFchevron_right
Are the Serum Biomarkers Pepsinogen I and II Good Predictors for the Detection of Subjects with Atrophic Gastritis in Areas that have Different Gastric Cancer Incidence?
arghavan sheykholeslami
Archives of Iranian medicine
View PDFchevron_right
Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
Renato Cannizzaro
Clinical and translational gastroenterology, 2016
View PDFchevron_right
Serum Pepsinogen Levels, Helicobacter pylori CagA Status, and Cytokine Gene Polymorphisms Associated with Gastric Premalignant Lesions in Costa Rica
Ana Lucia Valerin
Cancer Epidemiology Biomarkers & Prevention, 2007
View PDFchevron_right
Screening of precancerous gastric lesions by serum pepsinogen, gastrin-17, anti-helicobacter pylori and anti- CagA antibodies in dyspeptic patients over 50 years old in Guilan Province, north of Iran
Fariborz Mansour-ghanaei
Asian Pacific journal of cancer prevention : APJCP, 2014
View PDFchevron_right
Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population
Reza Taslimi
Medical journal of the Islamic Republic of Iran, 2014
View PDFchevron_right
Diagnosis of gastric adenocarcinoma using a scoring system: Combined assay of serological markers ofHelicobacter pylori infection, pepsinogen I and gastrin
Jawtown Lin
Journal of Gastroenterology, 1995
View PDFchevron_right
Serum pepsinogen test for early detection of gastric cancer in a European Country
Bento Bento
European Journal of Gastroenterology & Hepatology, 2012
View PDFchevron_right
Long-Term Results of Gastric Cancer Screening Using the Serum Pepsinogen Test Method Among an Asymptomatic Middle-Aged Japanese Population
Mitsuhiro Fujishiro
Digestive Endoscopy, 2009
View PDFchevron_right
Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community
Xin Xing
International Journal of Cancer, 2012
View PDFchevron_right
Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions
Fariborz Mansour-ghanaei
2013
View PDFchevron_right
Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer
Lina Huang
Scientific Reports, 2014
View PDFchevron_right
Usefulness of Serum Pepsinogen Levels as a Screening Test For Atrophic Gastritis and Gastric Cancer
F. Albayrak
The Eurasian Journal of Medicine, 2010
View PDFchevron_right
Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment—Results from the GISTAR Pilot Study
Lilian Tzivian
Diagnostics
View PDFchevron_right
Serum pepsinogen and Helicobacter pylori infection—a Japanese population study
Y. Urita
European Journal of Clinical Microbiology & Infectious Diseases, 2012
View PDFchevron_right
Clinical Significance of IgG Antibody Titer against Helicobacter pylori
Masayuki Tatemichi
Helicobacter, 2009
View PDFchevron_right
Combined Gastric and Colorectal Cancer Screening—A New Strategy
Peter Malfertheiner
International Journal of Molecular Sciences, 2018
View PDFchevron_right
Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations
Gontar Siregar
PLOS ONE
View PDFchevron_right
Gastric cancer: prevention, screening and early diagnosis
Evgeny Fedorov
World journal of gastroenterology : WJG, 2014
View PDFchevron_right
Serum pepsinogen as a new marker for gastric carcinoma among young adults
Yutaka Inaba
Cancer, 1994
View PDFchevron_right